Abstract
Purpose :
Retinopathy of Prematurity (ROP) diagnosis is made by subjective assessment of the amount of retina vascularized (zone), degree of abnormality at the avascular border (stage), and degree of vascular severity (plus disease). Previous work using deep learning has led to automated diagnosis of plus disease. The purpose of this study was to implement a deep convolutional neural network (CNN) for automated assessment of the presence of stage in retinal fundus images.
Methods :
Our training dataset includes 4441 images from 9 academic institutions participating in the Imaging and Informatics in ROP (i-ROP) cohort study. Image sets were collected from preterm infants undergoing routine screening and were graded for the presence of stage for each patient (defined as stage > 0 based on all fields of view) by 3 independent experts. Nasal, posterior, and temporal images for patients with visible stage were manually reviewed to identify specific images in the image set with disease. Image preprocessing was performed via contrast enhancement to enhance stage and vascular visibility and a Wiener filter for denoising. A binary CNN classifier using ResNet-152 was trained using 5-fold cross validation and subsequently evaluated on a held-out test set of 1111 images. Each validation and test set were adjusted to remove patient overlap. Diagnostic accuracy was evaluated using the area under the curve - receiving operating characteristics (AUC-ROC) curve, sensitivity, and specificity.
Results :
Of the 4441 included images in the training set, 1402 images were labeled by the 3 experts with visible stage, and 3038 images were labeled as normal. For 5-fold cross validation, the mean AUC-ROC score was 0.98 (SD 0.01). On the test set, the AUC-ROC score was 0.98, and the algorithm achieved a sensitivity of 91.1% and specificity of 97.6%.
Conclusions :
This automated CNN shows strong predictive performance for the presence of stage in ROP. This suggests the possibility for automated ROP detection and disease monitoring in telemedicine programs.
This is a 2020 ARVO Annual Meeting abstract.